These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16674936)

  • 1. The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family.
    Gibson LC; Hastings SF; McPhee I; Clayton RA; Darroch CE; Mackenzie A; Mackenzie FL; Nagasawa M; Stevens PA; Mackenzie SJ
    Eur J Pharmacol; 2006 May; 538(1-3):39-42. PubMed ID: 16674936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
    Gupta R; Kumar G; Kumar RS
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential inhibition of human phosphodiesterase 4 by ibudilast.
    Huang Z; Liu S; Zhang L; Salem M; Greig GM; Chan CC; Natsumeda Y; Noguchi K
    Life Sci; 2006 May; 78(23):2663-8. PubMed ID: 16313925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
    Lugnier C
    Pharmacol Ther; 2006 Mar; 109(3):366-98. PubMed ID: 16102838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?
    Albrecht K; Uckert S; Oelke M; Andersson KE; Jonas U; Tröger HD; Hedlund P
    J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclic nucleotides phosphodiesterases inhibitors].
    Hagiwara M; Hidaka H
    Nihon Rinsho; 1991 Sep; 49(9):1993-8. PubMed ID: 1660084
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and molecular genetics of the phosphodiesterases (PDEs).
    Azevedo MF; Faucz FR; Bimpaki E; Horvath A; Levy I; de Alexandre RB; Ahmad F; Manganiello V; Stratakis CA
    Endocr Rev; 2014 Apr; 35(2):195-233. PubMed ID: 24311737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.
    Kyoi T; Oka M; Noda K; Ukai Y
    Life Sci; 2004 Aug; 75(15):1833-42. PubMed ID: 15302227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update view on the substrate recognition mechanism of phosphodiesterases: a computational study of PDE10 and PDE4 bound with cyclic nucleotides.
    Lau JK; Cheng YK
    Biopolymers; 2012 Nov; 97(11):910-22. PubMed ID: 22899366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotide specific phosphodiesterases of Leishmania major.
    Johner A; Kunz S; Linder M; Shakur Y; Seebeck T
    BMC Microbiol; 2006 Mar; 6():25. PubMed ID: 16522215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S; Lohse MJ; Nikolaev VO
    Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterases in the central nervous system.
    Kleppisch T
    Handb Exp Pharmacol; 2009; (191):71-92. PubMed ID: 19089326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE inhibition and cognition enhancement.
    Blokland A; Menniti FS; Prickaerts J
    Expert Opin Ther Pat; 2012 Apr; 22(4):349-54. PubMed ID: 22475506
    [No Abstract]   [Full Text] [Related]  

  • 17. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi.
    Kunz S; Oberholzer M; Seebeck T
    FEBS J; 2005 Dec; 272(24):6412-22. PubMed ID: 16336277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
    Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
    Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase genes and antidepressant treatment response: a review.
    Esposito K; Reierson GW; Luo HR; Wu GS; Licinio J; Wong ML
    Ann Med; 2009; 41(3):177-85. PubMed ID: 18932104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of renal ecto-phosphodiesterase.
    Jackson EK; Ren J; Zacharia LC; Mi Z
    J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.